Yi Li

Affiliations: 
1997-2002 NCI  NIH, Sloan Kettering 
Google:
"Yi Li"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lu Y, Chen D, Wang B, et al. (2024) Single-cell landscape of undifferentiated pleomorphic sarcoma. Oncogene
Jiang S, Yang S, Gao Z, et al. (2024) An integrative pan-cancer bioinformatics analysis of MSRB1 and its association with tumor immune microenvironment, prognosis, and immunotherapy. Heliyon. 10: e26090
Ren B, Li Y, DI L, et al. (2024) A naturally derived small molecule compound suppresses tumor growth and metastasis in mice by relieving p53-dependent repression of CDK2/Rb signaling and the Snail-driven EMT. Chinese Journal of Natural Medicines. 22: 112-126
Yue F, Ku AT, Stevens PD, et al. (2024) Loss of ZNRF3/RNF43 Unleashes EGFR in Cancer. Biorxiv : the Preprint Server For Biology
Bu W, Li Y. (2023) In Vivo Gene Delivery into Mouse Mammary Epithelial Cells Through Mammary Intraductal Injection. Journal of Visualized Experiments : Jove
Dong R, Yang R, Zhan Y, et al. (2020) Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma. Cancer Cell
Zhang R, Chen C, Dong X, et al. (2020) Independent validation of early-stage NSCLC prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main effects. Chest
Ide H, Mizushima T, Jiang G, et al. (2020) FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cells. Endocrine-Related Cancer
Bu W, Liu Z, Jiang W, et al. (2018) Mammary precancerous stem and non-stem cells evolve into cancers of distinct subtypes. Cancer Research
Johnston AN, Bu W, Hein S, et al. (2018) Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Research : Bcr. 20: 42
See more...